Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Bhash Parasuraman"'
Autor:
Yoon-La Choi, Jong-Mu Sun, Juhee Cho, Sanjay Rampal, Joungho Han, Bhash Parasuraman, Eliseo Guallar, Genehee Lee, Jeeyun Lee, Young Mog Shim
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e56011 (2013)
INTRODUCTION: Guidelines for management of non-small cell lung cancer (NSCLC) strongly recommend EGFR mutation testing. These recommendations are particularly relevant in Asians that have higher EGFR mutation prevalence. This study aims to explore cu
Externí odkaz:
https://doaj.org/article/63514afa570941a589fa4a27794bbdc5
Autor:
Anuja, Roy, Andrew, Peterson, Nick, Marchant, Jose, Alvir, Rahul, Bhambri, Zach, Bredl, Darrin, Benjumea, Jason, Kemner, Bhash, Parasuraman
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 28:766-777
Publikováno v:
Circulation. 142
Publikováno v:
Journal of Asthma. 47:217-223
Assessment of patient-reported outcomes is important in evaluating the impact of asthma treatment. This study was conducted to compare effects of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler with fixed-dose flutic
Publikováno v:
Current Medical Research and Opinion. 25:929-942
As the role and importance of patient-reported outcomes (PROs) increase, the validity and reliability of PRO measures come under greater scientific and regulatory scrutiny. One key issue is selecting the 'most appropriate' recall period for capturing
Autor:
Kevin R. Murphy, Christopher J. Miller, Robert Boggs, Harold S. Nelson, Bhash Parasuraman, L. O'Dowd
Publikováno v:
Current Medical Research and Opinion. 24:879-894
To determine the effects of budesonide and formoterol administered via one pressurized metered-dose inhaler (budesonide/formoterol pMDI) on patient-reported outcomes (PROs) and to determine the contributions of budesonide and formoterol to those effe
Publikováno v:
Value in Health. 10:S86-S93
At its most elemental, patient-reported outcomes (PRO) assessment involves asking the patients questions and evaluating their answers. Instrument developers need to be clear about what they want to know, from whom they want to know it and why, whethe
Autor:
Michael Mellon, Stefan Walzer, William Hitchcock, Sulabha Ramachandran, Marcos Memran, Bhash Parasuraman
Publikováno v:
Advances in Therapy. 24:1240-1253
This study was conducted to assess caregiver preferences for pediatric asthma treatment delivery systems. A total of 186 caregivers of children with asthma who ranged in age from 1 to 4 y completed a stated-preference questionnaire to assess the impo
Publikováno v:
Annals of Allergy, Asthma & Immunology. 97:236-243
The burden of asthma is substantial, and the overall cost of its management is growing.To compare asthma-related charges and resource utilization across disease severity levels in the year after initial asthma treatment with any inhaled corticosteroi
Autor:
Thomas B. Casale, Harold S. Nelson, Bhash Parasuraman, Thomas Uryniak, James P. Kemp, Bengt Liljas
Publikováno v:
Annals of Allergy, Asthma & Immunology. 90:323-330
Background Budesonide inhalation powder administered via Turbuhaler (budesonide Turbuhaler, AstraZeneca LP, Wilmington, DE) is proven efficacious and safe in the treatment of mild to severe asthma. Objective To evaluate the effect of once-daily budes